1. True North Therapeutics Appoints Biotechnology Commercial Executive to its Board Of Directors

    True North Therapeutics Appoints Biotechnology Commercial Executive to its Board Of Directors

    True North Therapeutics, a clinical stage biotechnology company developing novel product candidates that selectively inhibit the Complement system, today announced that the company has appointed Jeff Ajer, Executive Vice President and Chief Commercial Officer of BioMarin, as an independent director to the company’s board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are delighted that Jeff has joined our board.
    2. True North is making significant progress advancing drug candidates that address a fundamental pathway driving numerous rare diseases.
  3. Topics Mentioned